131 related articles for article (PubMed ID: 10708962)
1. Gastro-intestinal tumorigenesis in Smad4 mutant mice.
Taketo MM; Takaku K
Cytokine Growth Factor Rev; 2000; 11(1-2):147-57. PubMed ID: 10708962
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal tumorigenesis in Smad4 (Dpc4) mutant mice.
Taketo MM; Takaku K
Hum Cell; 2000 Sep; 13(3):85-95. PubMed ID: 11197776
[TBL] [Abstract][Full Text] [Related]
3. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes.
Takaku K; Oshima M; Miyoshi H; Matsui M; Seldin MF; Taketo MM
Cell; 1998 Mar; 92(5):645-56. PubMed ID: 9506519
[TBL] [Abstract][Full Text] [Related]
4. No effects of Smad2 (madh2) null mutation on malignant progression of intestinal polyps in Apc(delta716) knockout mice.
Takaku K; Wrana JL; Robertson EJ; Taketo MM
Cancer Res; 2002 Aug; 62(16):4558-61. PubMed ID: 12183405
[TBL] [Abstract][Full Text] [Related]
5. Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice.
Takaku K; Miyoshi H; Matsunaga A; Oshima M; Sasaki N; Taketo MM
Cancer Res; 1999 Dec; 59(24):6113-7. PubMed ID: 10626800
[TBL] [Abstract][Full Text] [Related]
6. [Gastrointestinal tumorigenesis in Smad4 mutant mice].
Takaku K; Taketo M
Tanpakushitsu Kakusan Koso; 2001 Feb; 46(2):117-23. PubMed ID: 11211785
[No Abstract] [Full Text] [Related]
7. Comprehensive analysis of SMAD4 mutations and protein expression in juvenile polyposis: evidence for a distinct genetic pathway and polyp morphology in SMAD4 mutation carriers.
Woodford-Richens KL; Rowan AJ; Poulsom R; Bevan S; Salovaara R; Aaltonen LA; Houlston RS; Wright NA; Tomlinson IP
Am J Pathol; 2001 Oct; 159(4):1293-300. PubMed ID: 11583957
[TBL] [Abstract][Full Text] [Related]
8. Role of Smad4 (DPC4) inactivation in human cancer.
Miyaki M; Kuroki T
Biochem Biophys Res Commun; 2003 Jul; 306(4):799-804. PubMed ID: 12821112
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps.
Seno H; Oshima M; Ishikawa TO; Oshima H; Takaku K; Chiba T; Narumiya S; Taketo MM
Cancer Res; 2002 Jan; 62(2):506-11. PubMed ID: 11809702
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the SMAD4/DPC4 gene in juvenile polyposis.
Howe JR; Roth S; Ringold JC; Summers RW; Järvinen HJ; Sistonen P; Tomlinson IP; Houlston RS; Bevan S; Mitros FA; Stone EM; Aaltonen LA
Science; 1998 May; 280(5366):1086-8. PubMed ID: 9582123
[TBL] [Abstract][Full Text] [Related]
11. Carcinogen-induced pancreatic lesions in the mouse: effect of Smad4 and Apc genotypes.
Cullingworth J; Hooper ML; Harrison DJ; Mason JO; Sirard C; Patek CE; Clarke AR
Oncogene; 2002 Jul; 21(30):4696-701. PubMed ID: 12096346
[TBL] [Abstract][Full Text] [Related]
12. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p.
Abraham SC; Wu TT; Klimstra DS; Finn LS; Lee JH; Yeo CJ; Cameron JL; Hruban RH
Am J Pathol; 2001 Nov; 159(5):1619-27. PubMed ID: 11696422
[TBL] [Abstract][Full Text] [Related]
13. Vessels' morphology in SMAD4 and BMPR1A-related juvenile polyposis.
Handra-Luca A; Condroyer C; de Moncuit C; Tepper M; Fléjou JF; Thomas G; Olschwang S
Am J Med Genet A; 2005 Oct; 138A(2):113-7. PubMed ID: 16152648
[TBL] [Abstract][Full Text] [Related]
14. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
Li Q; Ishikawa TO; Oshima M; Taketo MM
Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
[TBL] [Abstract][Full Text] [Related]
15. Low prevalence of loss of heterozygosity and SMAD4 mutations in sporadic and familial juvenile polyposis syndrome-associated juvenile polyps.
Fogt F; Brown CA; Badizadegan K; Zimmerman RL; Odze R
Am J Gastroenterol; 2004 Oct; 99(10):2025-31. PubMed ID: 15447767
[TBL] [Abstract][Full Text] [Related]
16. Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice.
Philipp-Staheli J; Kim KH; Payne SR; Gurley KE; Liggitt D; Longton G; Kemp CJ
Cancer Cell; 2002 May; 1(4):355-68. PubMed ID: 12086850
[TBL] [Abstract][Full Text] [Related]
17. Orofacial and gastrointestinal hyperplasia and neoplasia in smad4+/- and elf+/-/smad4+/- mutant mice.
Redman RS; Katuri V; Tang Y; Dillner A; Mishra B; Mishra L
J Oral Pathol Med; 2005 Jan; 34(1):23-9. PubMed ID: 15610403
[TBL] [Abstract][Full Text] [Related]
18. Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice.
Oshima H; Oshima M; Kobayashi M; Tsutsumi M; Taketo MM
Cancer Res; 1997 May; 57(9):1644-9. PubMed ID: 9135000
[TBL] [Abstract][Full Text] [Related]
19. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice.
Xu X; Brodie SG; Yang X; Im YH; Parks WT; Chen L; Zhou YX; Weinstein M; Kim SJ; Deng CX
Oncogene; 2000 Apr; 19(15):1868-74. PubMed ID: 10773876
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
